- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03604081
Effectiveness of Modified Constraint Induced Movement Therapy to Improve Lower Extremity Function in the Acute and Subacute Stroke Patients by Providing 1 Hour of Intense Massed Practice in the Form of Shaping or Task Practice
August 31, 2020 updated by: NYU Langone Health
Effectiveness of Modified Constraint Induced Movement Therapy to Improve Lower Extremity Function in the Acute and Subacute Stroke Patients by Providing 1 Hour of Intense Massed Practice in the Form of Shaping or Task Practice, 7 Times Per Week for 2 Weeks.
This is a prospective randomized control trial of patients with unilateral impairment of the lower extremity after stroke.
Patients will be randomized to intervention group and control group.
Intervention group will receive one hour of intense massed practice of lower extremity either in the form of shaping or task practice.
Control group will receive conventional physical therapy for 1 hour as per current standard of care that follows stroke clinical practice guideline.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
53 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 55 or older
- new ischemic stroke as revealed by CT scan or MRI of a brain or as per updated definition by American heart and American stroke association (Sacco et al., 2013)
- Manual muscle testing with grad of > 1+ in hip and knee joint musculature
- able to walk atleast 10 feet indoors with or without assistance and assistive device.
- Motivated to participate and some initiation of flexion and extension movement in hip, knee and ankle joints.
- Ability to follow visual/verbal instructions as assessed by a minimum score of 24/30 points on the minimental state examination
- Fairly intact sensation
Exclusion Criteria:
- Serious cardiac or pulmonary condition or other medical condition that make it difficult or risky to participate in intensive training
- Severe joint pain or degenerative disease to the musculoskeletal system of the lower extremity
- other neurological disease 4) problems with following instructions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group
One hour of intense massed practice of lower extremity either in the form of shaping or task practice
|
Intervention group will receive one hour of intense massed practice of lower extremity either in the form of shaping or task practice.
|
Placebo Comparator: Control Group
Conventional physical therapy for 1 hour as per current standard of care that follows stroke clinical practice guideline.
|
1 hour as per current standard of care that follows stroke clinical practice guideline.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cycle time as measured by GAITRite.
Time Frame: 2 Weeks
|
GAITrite is considered a gold standard for gait analysis.
It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.
|
2 Weeks
|
step length as measured by GAITRite.
Time Frame: 2 Weeks
|
GAITrite is considered a gold standard for gait analysis.
It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.
|
2 Weeks
|
Stride length as measured by GAITRite.
Time Frame: 2 Weeks
|
GAITrite is considered a gold standard for gait analysis.
It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.
|
2 Weeks
|
velocity as measured by GAITRite
Time Frame: 2 Weeks
|
GAITrite is considered a gold standard for gait analysis.
It consists of a mat with the sensors which are pressure sensitive and when patient ambulates on the mat the system measures parameters like step length, stride length, cycle time and velocity.
|
2 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nada Abou-Fayssal, MD, NYU Langone Health
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 11, 2018
Primary Completion (Actual)
August 14, 2020
Study Completion (Actual)
August 14, 2020
Study Registration Dates
First Submitted
July 18, 2018
First Submitted That Met QC Criteria
July 18, 2018
First Posted (Actual)
July 27, 2018
Study Record Updates
Last Update Posted (Actual)
September 2, 2020
Last Update Submitted That Met QC Criteria
August 31, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-00773
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
Clinical Trials on CIMT
-
Riphah International UniversityCompletedHemiplegic Cerebral PalsyPakistan
-
Uludag UniversityCompleted
-
CEU San Pablo UniversityUnknownUpper Extremity Paresis | Family | Infantile Hemiplegia | Constraint Induced Movement Therapy | Bimanual Intensive TherapySpain
-
Riphah International UniversityCompleted
-
Riphah International UniversityCompletedCerebral Palsy | Hemiplegic Cerebral PalsyPakistan
-
Walter Reed National Military Medical CenterHenry M. Jackson Foundation for the Advancement of Military MedicineCompletedCardiovascular DiseaseUnited States
-
Kelly TannerCompletedCerebral Palsy | Cerebral Palsy, Diplegic, InfantileUnited States
-
Alyn Pediatric & Adolescent Rehabilitation HospitalUnknownCerebral Palsy | Hand Function
-
Holland Bloorview Kids Rehabilitation HospitalCompletedHemiplegic Cerebral PalsyCanada
-
Samsung Medical CenterCompletedCerebral Palsy, Spastic HemiplegicKorea, Republic of